Amedeo Smart

Free Medical Literature Service


 

Amedeo

Stroke

  Free Subscription

Articles published in
Int J Cardiol
    November 2022
  1. ZUERCHER MD, Harvey DJ, Au LE, Shadyab AH, et al
    Genetic admixture and cardiovascular disease risk in postmenopausal Hispanic women.
    Int J Cardiol. 2022;367:99-104.
    >> Share

  2. DU L, Zhang Y, Wang P, Li Z, et al
    GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?
    Int J Cardiol. 2022;366:31.
    >> Share

    October 2022
  3. OLIVERI F, Montalto C, Tua L, Lanzillo G, et al
    Direct oral anticoagulants or vitamin K antagonists after TAVR: A systematic review and meta-analysis.
    Int J Cardiol. 2022;365:123-130.
    >> Share

    September 2022
  4. MAI AS, Matetic A, Elgendy IY, Mattei JL, et al
    The Association Between Cancer Diagnosis, Care, and Outcomes in 1 Million Patients Hospitalized for Acute Pulmonary Embolism.
    Int J Cardiol. 2022 Sep 24. pii: S0167-5273(22)01399.
    >> Share

  5. SOKHAL BS, Matetic A, Paul TK, Velagapudi P, et al
    Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01387.
    >> Share

  6. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    >> Share

  7. VERGARO G, Aimo A, Castiglione V, Emdin M, et al
    Stroke in ATTR cardiac amyloidosis: Does only rhythm matter?
    Int J Cardiol. 2022;363:127-128.
    >> Share

  8. PEREIRA MQ, David C, Almeida AG, Brito D, et al
    Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis.
    Int J Cardiol. 2022;362:76-82.
    >> Share

    August 2022
  9. HWANG IC, Kim CH
    Reply to "GLP1RA versus SGLT2i tended to have more favorable ischemic outcomes including stroke?"
    Int J Cardiol. 2022 Aug 23. pii: S0167-5273(22)01257.
    >> Share

  10. IWAKAWA H, Terata K, Kato R, Kaimori R, et al
    Utility of P-wave abnormalities for distinguishing embolic stroke from non-embolic stroke.
    Int J Cardiol. 2022 Aug 23. pii: S0167-5273(22)01247.
    >> Share

    July 2022
  11. DE LUCA G, Verdoia M, Morici N, Ferri LA, et al
    Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial.
    Int J Cardiol. 2022 Jul 27. pii: S0167-5273(22)01104.
    >> Share

  12. LUNARDI M, Venturi G, Del Sole PA, Ruzzarin A, et al
    Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 21. pii: S0167-5273(22)01100.
    >> Share

  13. MOLEK P, Chmiel J, Zabczyk M, Malinowski KP, et al
    Elevated 8-isoprostane concentration is associated with thromboembolic events in patients with atrial fibrillation.
    Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01103.
    >> Share

  14. DIXON LK, Akberali U, Di Tommaso E, George SJ, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022;359:20-27.
    >> Share

  15. GOEL A, Singhal M, Malik AH, Gupta R, et al
    Patent foramen ovale closure for recurrent stroke prevention: Recent evidence towards individualized decision-making.
    Int J Cardiol. 2022;358:25.
    >> Share

    June 2022
  16. KORSHOLM K, Valentin JB, Damgaard D, Diener HC, et al
    Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
    Int J Cardiol. 2022 Jun 30. pii: S0167-5273(22)01019.
    >> Share

  17. BAKER HE, Tune JD, Mather KJ, Blaettner BS, et al
    Acute SGLT-2i treatment improves cardiac efficiency during myocardial ischemia independent of Na+/H+ exchanger-1.
    Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01006.
    >> Share

  18. KIM CH, Hwang IC, Choi HM, Ahn CH, et al
    Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00927.
    >> Share

  19. KANY S, Kuck KH, Brachmann J, Andresen D, et al
    Outcomes in patients experiencing complications associated with atrial fibrillation ablation: Data from the German ablation registry.
    Int J Cardiol. 2022 Jun 12. pii: S0167-5273(22)00918.
    >> Share

    May 2022
  20. KE Y, Wang J, Wang W, Guo S, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
    >> Share

  21. PRACON R, Zielinski K, Bangalore S, Konka M, et al
    Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
    Int J Cardiol. 2022;354:17-21.
    >> Share

    April 2022
  22. DALE Z, Chandrashekar P, Al-Rashdan L, Gill S, et al
    Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin cardiac amyloidosis.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00559.
    >> Share

  23. XUE W, Tian Y, Jing L, Li R, et al
    Sex difference in the correlation between carotid artery diameter and prevalence of stroke: Insights from a Chinese population.
    Int J Cardiol. 2022;353:103-108.
    >> Share

  24. JOLOBE OMP
    Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00509.
    >> Share

  25. LI L, Dai M, Fu Y
    Non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00508.
    >> Share

  26. MASSUSSI M, Cipriani A, Meneghin S, De la Cruz N, et al
    Prognostic value of left ventricular blood stasis in patients with acute myocardial infarction: A cardiac magnetic resonance study.
    Int J Cardiol. 2022 Apr 6. pii: S0167-5273(22)00492.
    >> Share

    March 2022
  27. WANG W, Huang Q, Pan D, Zheng W, et al
    The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Int J Cardiol. 2022 Mar 29. pii: S0167-5273(22)00441.
    >> Share

  28. SADEGHIPOUR P, Pouraliakbar H, Parsaee M, Shojaeifard M, et al
    RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00396.
    >> Share

    February 2022
  29. MAGNANI G, Bricoli S, Ardissino M, Maglietta G, et al
    Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA).
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00249.
    >> Share

  30. GONZALEZ PEREZ A, Balabanova Y, Saez ME, Brobert G, et al
    Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom.
    Int J Cardiol. 2022 Feb 2. pii: S0167-5273(22)00190.
    >> Share

  31. ORSINI E, Marzilli M, Zito GB, Carbone V, et al
    Clinical outcomes of newly diagnosed, stable angina patients managed according to current guidelines. The ARCA (Arca Registry for Chronic Angina) Registry: A prospective, observational, nationwide study.
    Int J Cardiol. 2022 Feb 1. pii: S0167-5273(22)00182.
    >> Share

    January 2022
  32. LI X, Jia Z, Yan Y
    Ticagrelor for prevention of stroke and cognitive impairment in patients with vascular high-risk factors: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 Jan 31. pii: S0167-5273(22)00186.
    >> Share

  33. FU EL, Clase CM, Janse RJ, Lindholm B, et al
    Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00131.
    >> Share

    December 2021
  34. HUANG CK, Wang JC, Chung CH, Chen SJ, et al
    The risk and timing of acute ischemic stroke after electrical cardioversion for atrial fibrillation in Taiwan: A nationwide population-based cohort study.
    Int J Cardiol. 2021 Dec 23. pii: S0167-5273(21)02038.
    >> Share

  35. D'ANCONA G, Arslan F, Safak E, Weber D, et al
    Actual management costs of patients with non-valvular atrial fibrillation treated with percutaneous left atrial appendage closure or oral anticoagulation.
    Int J Cardiol. 2021 Dec 17. pii: S0167-5273(21)02019.
    >> Share

  36. DI LULLO L, Lavalle C, Magnocavallo M, Mariani MV, et al
    New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation.
    Int J Cardiol. 2021;345:90-97.
    >> Share

  37. BONAVENTURA A
    Assisted reproductive technologies and stroke: Risk factor, predictor of poor outcome, or both?
    Int J Cardiol. 2021;344:220-221.
    >> Share

    November 2021
  38. TANG Y, Liu S, Shi Y, He T, et al
    Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction.
    Int J Cardiol. 2021 Nov 24. pii: S0167-5273(21)01861.
    >> Share

  39. RAHMAN MU, Amritphale A, Kumar S, Trice C, et al
    Assessment of independent clinical predictors of early readmission after percutaneous endoluminal left atrial appendage closure with the Watchman device using National Readmission Database.
    Int J Cardiol. 2021;343:21-26.
    >> Share

  40. BONETTI NR, Meister TA, Soria R, Akhmedov A, et al
    In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.
    Int J Cardiol. 2021;343:92-101.
    >> Share

  41. MARSTON XL, Wang R, Yeh YC, Zimmermann L, et al
    Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study.
    Int J Cardiol. 2021 Nov 12. pii: S0167-5273(21)01776.
    >> Share

  42. ZHENG X, Wang F, Zhang J, Cui X, et al
    Using machine learning to predict atrial fibrillation diagnosed after ischemic stroke.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01773.
    >> Share

  43. SILVERIO A, Di Maio M, Buccheri S, De Luca G, et al
    Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01784.
    >> Share

    September 2021
  44. RADINOVIC A, Falasconi G, Marzi A, D'Angelo G, et al
    Long-term outcome of left atrial appendage occlusion with multiple devices.
    Int J Cardiol. 2021 Sep 29. pii: S0167-5273(21)01492.
    >> Share

  45. LENG WX, Yang YJ
    Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01484.
    >> Share

  46. SHANG L, Sun H, Tang B
    Screening for atrial fibrillation in older populations: Outcome is more important than detection.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01486.
    >> Share

  47. SPARROW RT, Sanjoy SS, Lindman BR, Tang GHL, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing transcatheter mitral edge-to-edge repair.
    Int J Cardiol. 2021 Sep 20. pii: S0167-5273(21)01478.
    >> Share

  48. AIT-OUFELLA H, Yu M, Kotti S, Georges A, et al
    Plasma and genetic determinants of soluble TREM-1 and major adverse cardiovascular events in a prospective cohort of acute myocardial infarction patients. Results from the FAST-MI 2010 study.
    Int J Cardiol. 2021 Sep 15. pii: S0167-5273(21)01379.
    >> Share

  49. AL-RUBAISH AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, et al
    Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients.
    Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01319.
    >> Share

  50. ANDERSEN P, Kragholm K, Torp-Pedersen C, Jensen SE, et al
    The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction.
    Int J Cardiol. 2021 Sep 6. pii: S0167-5273(21)01321.
    >> Share

    August 2021
  51. WANG W, Liu Y, Liu J, Yin P, et al
    Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: Empirical evidence from national mortality surveillance system.
    Int J Cardiol. 2021 Aug 25. pii: S0167-5273(21)01300.
    >> Share

  52. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    >> Share

  53. SEN J, Tonkin A, Varigos J, Fonguh S, et al
    Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease.
    Int J Cardiol. 2021;337:9-15.
    >> Share

  54. ZUIN M, Rigatelli G
    Thrombus straddling a patent foramen ovale: Also a myocardial infarction matter?
    Int J Cardiol. 2021 Aug 7. pii: S0167-5273(21)01206.
    >> Share

    July 2021
  55. JAMAL J, O'Loughlin A, French JK
    A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Jul 31. pii: S0167-5273(21)01210.
    >> Share

  56. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    >> Share

  57. JACOBSEN MR, Engstrom T, Torp-Pedersen C, Gislason G, et al
    Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01192.
    >> Share

  58. NEDIOS S
    Screening for atrial fibrillation: Does cardiovascular disease reduce the probability of detection?
    Int J Cardiol. 2021 Jul 14. pii: S0167-5273(21)01097.
    >> Share

  59. VEDOVATI MC, Tratar G, Mavri A, Mazzetti M, et al
    Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01099.
    >> Share

  60. SHAH P, Jimenez-Ruiz A, Gibson A, Vargas-Gonzalez JC, et al
    Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01101.
    >> Share

    June 2021
  61. VAN DER MATEN G, Dijkstra S, Meijs MFL, von Birgelen C, et al
    Cardiac imaging in ischemic stroke or transient ischemic attack of undetermined cause: Systematic review & meta-analysis.
    Int J Cardiol. 2021 Jun 28. pii: S0167-5273(21)01083.
    >> Share

  62. FAROUX L, Cruz-Gonzalez I, Arzamendi D, Freixa X, et al
    Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Int J Cardiol. 2021;333:77-82.
    >> Share

    May 2021
  63. JANSSENS GN, Lemkes JS, van der Hoeven NW, van Leeuwen MAH, et al
    Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome.
    Int J Cardiol. 2021 May 15. pii: S0167-5273(21)00830.
    >> Share

  64. MINHAS A, Shade JK, Cho SM, Michos ED, et al
    The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19.
    Int J Cardiol. 2021 May 8. pii: S0167-5273(21)00823.
    >> Share

  65. MANNINA C, Jin Z, Matsumoto K, Ito K, et al
    Frequency of cardiac arrhythmias in older adults: Findings from the Subclinical Atrial Fibrillation and Risk of Ischemic Stroke (SAFARIS) study.
    Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00818.
    >> Share

  66. MIRO O, Llorens P, Jimenez S, Pinera P, et al
    Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2.
    Int J Cardiol. 2021;330:268-272.
    >> Share

  67. SHIN SY, Park JW
    Is the Left Atrial Appendage (LAA) anatomical shape really meaningless measure for stroke risk assessment?
    Int J Cardiol. 2021;330:80-81.
    >> Share

    April 2021
  68. LANGER A, Healey JS, Quinn FR, Honos G, et al
    Detection of atrial fibrillation in asymptomatic at-risk individuals.
    Int J Cardiol. 2021 Apr 28. pii: S0167-5273(21)00737.
    >> Share

  69. ELGENDY IY, Mansoor H, Pepine CJ
    Reproductive lifespan and incident stroke risk among post-menopausal women: Is it time for sex-specific risk prediction tools?
    Int J Cardiol. 2021;328:218-219.
    >> Share

  70. MISHRA SR, Waller M, Chung HF, Mishra GD, et al
    Association of the length of oestrogen exposure with risk of incident stroke in postmenopausal women: Insights from a 20-year prospective study.
    Int J Cardiol. 2021;328:206-214.
    >> Share

    March 2021
  71. GAWALKO M, Dobrev D
    Oral anticoagulation and therapy of atrial flutter: discontinuation of anticoagulation revisited.
    Int J Cardiol. 2021 Mar 17. pii: S0167-5273(21)00479.
    >> Share

  72. STRAW S, Witte KK
    Closing the loop: Delivering personalised care for patients with cryptogenic stroke.
    Int J Cardiol. 2021;327:100-101.
    >> Share

  73. KRISHNAPPA D, Wang W, Rooney MR, Norby FL, et al
    Life's Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00394.
    >> Share

  74. DE HEIDE J, de Wit A, Bhagwandien RE, Assaf A, et al
    Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population.
    Int J Cardiol. 2021;326:98-102.
    >> Share

    February 2021
  75. GIEHM-REESE M, Johansen MN, Kronborg MB, Jensen HK, et al
    Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study.
    Int J Cardiol. 2021 Feb 27. pii: S0167-5273(21)00366.
    >> Share

  76. KOZIEL M, Mihajlovic M, Nedeljkovic M, Pavlovic N, et al
    Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00294.
    >> Share

  77. COWAN LT, Buck B, Schwind JS, Lutsey PL, et al
    Triggering of cardiovascular disease by infection type: The Atherosclerosis Risk in Communities study (ARIC).
    Int J Cardiol. 2021;325:155-160.
    >> Share

  78. LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
    Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
    Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
    >> Share

    January 2021
  79. HARIHARAN P, Giordano N, Muzikansky A, Kabrhel C, et al
    Clinical factors associated with massive pulmonary embolism and PE-related adverse clinical events.
    Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00139.
    >> Share

  80. KALARIA SN, Zhu H, Liu Q, Florian J, et al
    Influence of age on the relationship between apixaban concentration and anti-factor Xa activity in older patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00106.
    >> Share

  81. DUDZINSKA-SZCZERBA K, Michalowska I, Piotrowski R, Sikorska A, et al
    Assessment of the left atrial appendage morphology in patients after ischemic stroke - The ASSAM study.
    Int J Cardiol. 2021 Jan 29. pii: S0167-5273(21)00080.
    >> Share

  82. ZWEIKER D, Manninger M, Sieghartsleitner R, Ebner J, et al
    No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation.
    Int J Cardiol. 2021 Jan 25. pii: S0167-5273(21)00082.
    >> Share

  83. DE ROQUETAILLADE C, Chousterman BG, Tomasoni D, Zeitouni M, et al
    Unusual arterial thrombotic events in Covid-19 patients.
    Int J Cardiol. 2021;323:281-284.
    >> Share

  84. HWANG J, Lee SR, Park HS, Lee YS, et al
    Adherence to dabigatran and the influence of dabigatran-induced gastrointestinal discomfort in the real-world practice.
    Int J Cardiol. 2021;323:77-82.
    >> Share

  85. GU K, Mahtta D, Kaneria A, Sharedalal P, et al
    Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR(R) PINNACLE Registry.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34312.
    >> Share

  86. SCOGNAMIGLIO G, Fusco F, Hankel TC, Bouma BJ, et al
    Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry.
    Int J Cardiol. 2021;322:129-134.
    >> Share

    December 2020
  87. FEMIA G, Zhu D, Choudhary P, Ross SB, et al
    Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults.
    Int J Cardiol. 2020 Dec 10. pii: S0167-5273(20)34265.
    >> Share

  88. LENG WX, Yang JG, Li XD, Jiang WY, et al
    Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China.
    Int J Cardiol. 2020 Dec 8. pii: S0167-5273(20)34245.
    >> Share

  89. CAPIAU A, De Backer T, Grymonprez M, Lahousse L, et al
    Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and EHRA Practical Guide.
    Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34231.
    >> Share

    November 2020
  90. KOBO O, Contractor T, Mohamed MO, Parwani P, et al
    Impact of pre-existent vascular and poly-vascular disease on acute myocardial infarction management and outcomes: An analysis of 2 million patients from the National Inpatient Sample.
    Int J Cardiol. 2020 Nov 30. pii: S0167-5273(20)34220.
    >> Share

  91. CASU G, D'Angelo G, Ugo F, Ronco F, et al
    Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study.
    Int J Cardiol. 2020 Nov 24. pii: S0167-5273(20)34168.
    >> Share

  92. DOMINGUEZ-ERQUICIA P, Raposeiras-Roubin S, Abbu-Assi E, Cespon-Fernandez M, et al
    Incidence, predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation.
    Int J Cardiol. 2020 Nov 18. pii: S0167-5273(20)34146.
    >> Share

  93. MARKS D, Ho R, Then R, Weinstock JL, et al
    Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia occurrence.
    Int J Cardiol. 2020 Nov 10. pii: S0167-5273(20)34140.
    >> Share

  94. ANDERSSON T, Aspberg S
    Age threshold for anticoagulation in patients with atrial fibrillation: A Swedish nationwide observational study.
    Int J Cardiol. 2020 Nov 2. pii: S0167-5273(20)34068.
    >> Share

    October 2020
  95. VALLABHAJOSYULA S
    Reply to 'The potentially fatal consequences of fibrinolysis in misdiagnosed patients with aortic dissection'.
    Int J Cardiol. 2020 Oct 5. pii: S0167-5273(20)33910.
    >> Share

  96. PANA TA, Mohamed MO, Clark AB, Fahy E, et al
    Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure.
    Int J Cardiol. 2020 Oct 3. pii: S0167-5273(20)33906.
    >> Share

  97. FENDER AC, Dobrev D
    The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillation.
    Int J Cardiol. 2020 Oct 1. pii: S0167-5273(20)33897.
    >> Share

    September 2020
  98. PACHOLCZAK-MADEJ R, Bazan-Socha S, Zareba L, Undas A, et al
    Direct oral anticoagulants in the prevention of stroke in breast cancer patients with atrial fibrillation during adjuvant endocrine therapy: A cohort study.
    Int J Cardiol. 2020 Sep 12. pii: S0167-5273(20)33818.
    >> Share

  99. JOLOBE OMP
    The potentially fatal consequences of fibrinolysis in misdiagnosed subjects with aortic dissection.
    Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33798.
    >> Share

    August 2020
  100. CHANTRARAT T, Krittayaphong R
    Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population,Data from the COOL-AF Thailand registry.
    Int J Cardiol. 2020 Aug 20. pii: S0167-5273(20)33651.
    >> Share

  101. LIU J, Wang Y, Guo W, Cheng Y, et al
    Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study.
    Int J Cardiol. 2020 Aug 16. pii: S0167-5273(20)33573.
    >> Share

  102. VALLABHAJOSYULA S, Verghese D, Subramaniam AV, Kumar V, et al
    Management and outcomes of uncomplicated ST-segment elevation myocardial infarction patients transferred after fibrinolytic therapy.
    Int J Cardiol. 2020 Aug 15. pii: S0167-5273(20)33539.
    >> Share

  103. CHANG KW, Xian Y, Zhao X, Mi X, et al
    Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke.
    Int J Cardiol. 2020 Aug 14. pii: S0167-5273(20)33538.
    >> Share

  104. RUTLAND J, Ayoub K, Etaee F, Ogunbayo G, et al
    CHA2DS2-VASc and readmission with new-onset atrial fibrillation, atrial flutter, or acute cerebrovascular accident.
    Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33554.
    >> Share

  105. MALAVASI VL, Zoccali C, Brandi MC, Micali G, et al
    Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study.
    Int J Cardiol. 2020 Aug 12. pii: S0167-5273(20)33555.
    >> Share

  106. CARRERO JJ, Trevisan M, Evans M, Svennberg E, et al
    Kidney function and the risk of heart failure in patients with new-onset atrial fibrillation.
    Int J Cardiol. 2020 Aug 5. pii: S0167-5273(20)33530.
    >> Share

    July 2020
  107. LOPES RD, Berger SE, Di Fusco M, Kang A, et al
    A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation.
    Int J Cardiol. 2020 Jul 4. pii: S0167-5273(20)33439.
    >> Share

    June 2020
  108. HUANG J, Wu N, Xiang Y, Wu L, et al
    Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation.
    Int J Cardiol. 2020 Jun 27. pii: S0167-5273(20)33408.
    >> Share

  109. AKHTAR T, Fratti JDC, Mattumpuram J, Fugar S, et al
    Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience.
    Int J Cardiol. 2020 Jun 26. pii: S0167-5273(20)33410.
    >> Share

  110. PATTI G, Pecen L, Manu MC, Huber K, et al
    Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies.
    Int J Cardiol. 2020 Jun 20. pii: S0167-5273(20)33388.
    >> Share

  111. LAUREANTI R, Conte G, Corino VDA, Osswald S, et al
    Response to "Electrocardiographic sexual differences in patients with atrial fibrillation".
    Int J Cardiol. 2020;308:50-51.
    >> Share

    May 2020
  112. LEIVO J, Anttonen E, Jolly SS, Dzavik V, et al
    The high-risk ECG pattern of ST-elevation myocardial infarction: A substudy of the randomized trial of primary PCI with or without routine manual thrombectomy (TOTAL trial).
    Int J Cardiol. 2020 May 26. pii: S0167-5273(20)31075.
    >> Share

  113. JAUME FP, Aleix OS, Nuria RG, Jordi PR, et al
    High incidence of subclinical atrial fibrillation in patients with syncope monitored with implantable cardiac monitor.
    Int J Cardiol. 2020 May 26. pii: S0167-5273(20)32451.
    >> Share

    April 2020
  114. PUGLIESE NR, Masi S
    Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease.
    Int J Cardiol. 2020 Apr 21. pii: S0167-5273(20)31424.
    >> Share

  115. GEARY L, Hasselstrom J, Carlsson AC, Schenck-Gustafsson K, et al
    An audit & feedback intervention for improved anticoagulant use in patients with atrial fibrillation in primary care.
    Int J Cardiol. 2020 Apr 12. pii: S0167-5273(20)30628.
    >> Share

    March 2020
  116. YUAN S, Lin A, He QQ, Burgess S, et al
    Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
    Int J Cardiol. 2020 Mar 21. pii: S0167-5273(20)30701.
    >> Share

  117. CHEN L, He W, Liu F, Wang T, et al
    Stroke in pulmonary hypertension: Is it predictable or preventable?
    Int J Cardiol. 2020;303:79.
    >> Share

  118. ZAKERI R, Morgan JM, Phillips P, Kitt S, et al
    Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2020 Mar 3. pii: S0167-5273(19)34926.
    >> Share

    February 2020
  119. NEDIOS S, Dobrev D
    Electrocardiographic sex-related differences in patients with atrial fibrillation: Do they allow a better risk stratification?
    Int J Cardiol. 2020 Feb 19. pii: S0167-5273(20)30218.
    >> Share

    January 2020
  120. BAE JH, Corban MT, Seo YH, Kim T, et al
    Ten-year clinical outcomes of an intermediate coronary lesion; prognosis and predictors of major adverse cardiovascular events.
    Int J Cardiol. 2020;299:26-30.
    >> Share

  121. LAUREANTI R, Conte G, Corino VDA, Osswald S, et al
    Sex-related electrocardiographic differences in patients with different types of atrial fibrillation: Results from the SWISS-AF study.
    Int J Cardiol. 2020 Jan 3. pii: S0167-5273(19)34685.
    >> Share

  122. MICHOU E, Gualandro D, Mueller C
    It is B-type and not brain natriuretic peptide after all.
    Int J Cardiol. 2020;298:114-115.
    >> Share

  123. RODRIGUEZ-CASTRO E, Hervella P, Lopez-Dequidt I, Arias-Rivas S, et al
    NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack.
    Int J Cardiol. 2020;298:93-97.
    >> Share

    December 2019
  124. BAHIT MC, Granger CB, Alexander JH, Mulder H, et al
    Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial.
    Int J Cardiol. 2019 Dec 30. pii: S0167-5273(19)34634.
    >> Share

  125. STEWART LK, Beam DM, Casciani T, Cameron SJ, et al
    Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis.
    Int J Cardiol. 2019 Dec 26. pii: S0167-5273(19)30431.
    >> Share

  126. HU QW, Bao TZ, Yang HR
    NT-pro-BNP: A promising predictor of stroke risk after transient ischemic attack.
    Int J Cardiol. 2019;297:142.
    >> Share

  127. SHAH TG, Sutaria JM, Vyas MV
    The association between pulmonary hypertension and stroke: a systematic review and meta-analysis.
    Int J Cardiol. 2019 Dec 12. pii: S0167-5273(19)35735.
    >> Share

    November 2019
  128. SPOSATO LA, Spence JD
    Patent foramen ovale in patients with atrial fibrillation.
    Int J Cardiol. 2019 Nov 22. pii: S0167-5273(19)35608.
    >> Share

  129. NAGAI M, Dote K, Kato M
    Left atrial fibrosis after ischemic stroke: How the insular cortex-ganglionated plexi axis interacts?
    Int J Cardiol. 2019;294:16.
    >> Share

  130. JAREMEK VM, Whitehead S, Sposato LA
    Lateralization of the control of cardiovascular autonomic function and left atrial injury after selective right and left insular stroke.
    Int J Cardiol. 2019;294:15.
    >> Share

    October 2019
  131. LUCIJANIC M, Jurin I, Jurin H, Lucijanic T, et al
    Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes.
    Int J Cardiol. 2019 Oct 30. pii: S0167-5273(19)34260.
    >> Share

  132. LI HL, Wu S, Chan YC, Cheng SW, et al
    Early and mid-term mortality and morbidity of contemporary international endovascular treatment for type B aortic dissection - A systematic review and meta-analysis.
    Int J Cardiol. 2019 Oct 24. pii: S0167-5273(19)31112.
    >> Share

    July 2019
  133. SHAH TG, Sutaria JM, Vyas MV
    The association between pulmonary hypertension and stroke: A systematic review and meta-analysis.
    Int J Cardiol. 2019 Jul 31. pii: S0167-5273(19)31075.
    >> Share

  134. BORIANI G, Healey JS, Schnabel RB, Lopes RD, et al
    Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group.
    Int J Cardiol. 2019 Jul 11. pii: S0167-5273(19)32817.
    >> Share

    May 2019
  135. BOTTO GL, Brasca FMA
    Stroke risk assessment in atrial fibrillation: Beyond atrial rhythm.
    Int J Cardiol. 2019 May 24. pii: S0167-5273(19)32435.
    >> Share

  136. STEPIEN K, Nowak K, Wypasek E, Zalewski J, et al
    High prevalence of inherited thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries: Comparison with cryptogenic stroke.
    Int J Cardiol. 2019 May 18. pii: S0167-5273(19)30879.
    >> Share

    December 2018
  137. LEONARD JR, Henry M, Rahouma M, Khan FM, et al
    Systematic preoperative CT scan is associated with reduced risk of stroke in minimally invasive mitral valve surgery: A meta-analysis.
    Int J Cardiol. 2018 Dec 12. pii: S0167-5273(18)35962.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016